Evidence map›Paper›PMID 31237232›Full record

ArticleThe American journal of tropical medicine and hygiene2019

Early Mortality among Immunocompetent Patients of Tuberculous Meningitis: A Prospective Study.

Ravi Shekhar Jaipuriar, Ravindra Kumar Garg, Imran Rizvi, Hardeep Singh Malhotra, Neeraj Kumar, Amita Jain, Rajesh Verma, Praveen Kumar Sharma, Shweta Pandey, Ravi Uniyal

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Authors' Response.The American journal of tropical medicine and hygiene · 2019
    Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ravi Shekhar JaipuriarDepartment of Neurology, King George Medical University, Lucknow, India.
Ravindra Kumar GargDepartment of Neurology, King George Medical University, Lucknow, India.
Imran RizviDepartment of Neurology, King George Medical University, Lucknow, India.
Hardeep Singh MalhotraDepartment of Neurology, King George Medical University, Lucknow, India.
Neeraj KumarDepartment of Neurology, King George Medical University, Lucknow, India.
Amita JainDepartment of Microbiology, King George Medical University, Lucknow, India.
Rajesh VermaDepartment of Neurology, King George Medical University, Lucknow, India.
Praveen Kumar SharmaDepartment of Neurology, King George Medical University, Lucknow, India.
Shweta PandeyDepartment of Neurology, King George Medical University, Lucknow, India.
Ravi UniyalDepartment of Neurology, King George Medical University, Lucknow, India.
King George's Medical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most deaths in tuberculous meningitis occur in the early part of the illness. We assessed the determinants of early deaths, occurring within 2 months of intensive therapy. We prospectively included consecutive newly diagnosed adults with HIV-negative tuberculous meningitis. Patients were given WHO-recommended antituberculosis treatment and were followed up for 9 months. We enrolled 152 patients. A total of 26 deaths were recorded during 2 months. The logistic regression analysis revealed that papilledema (

Indexed as

ImmunocompetenceSeverity of Illness IndexAdolescentAdultAntitubercular AgentsFemaleHumansMaleMiddle AgedOdds RatioPrognosisProspective StudiesRisk FactorsTime FactorsTuberculosis, MeningealYoung AdultAntitubercular Agents

Identifiers

PMID31237232
PMCPMC6685555
OpenAlexW2953976052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.